A Ph.D.-trained medicinal chemist with over 35 years of experience has built a career centered on pharmaceutical drug discovery across both industry and academic settings. His work spans the full lifecycle of small-molecule development, from early-stage screening through clinical advancement, with contributions across oncology, neurodegenerative disease, inflammation, and metabolic disorders. He has led discovery teams responsible for advancing compounds into clinical trials and is recognized as a co-inventor of therapeutics currently in late-stage development, including a PI3K/mTOR inhibitor for cancer and an ALS treatment candidate.

His expertise includes medicinal and computational chemistry, organic synthesis, ADME/PK evaluation, and compound optimization, along with deep experience in pharmaceutical intellectual property as an inventor on more than 60 patents and patent applications. He has authored over 140 scientific publications and continues to contribute to research and drug development in both biotechnology and academic environments. His background also supports analysis of drug composition, discovery strategy, and patent-related issues relevant to pharmaceutical disputes.